The success of an AIDS vaccine trial that in 2009 was shown to protect 31 percent of people studied may have been due to varying levels of antibody responses in the patients, researchers said Thursday. Different types of antibody responses were associated with who became infected and who did not,…
By Nora Eisenberg
Read More
By Amanda Marcotte
Read More
By Amanda Marcotte
Read More
Raw Story is a progressive news site that focuses on stories often ignored in the mainstream media. While giving coverage to the big stories of the day, we also bring our readers' attention to policy, politics, legal and human rights stories that get ignored in an infotainment culture driven solely by pageviews.
Founded in 2004, Raw Story reaches 5 million unique readers per month and serves more than 19 million pageviews.
Copyright © 2004-2013 Raw Story Media, Inc. All rights reserved.